radium-223,lutetium-177 psma-i&t
novartis,bayer
['alphabet', 'crpc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
tip: alphabet - ph i/ii trial evaluating ra-223 + lupsma-i&amp;t in mcrpc #gu23 enrol: 36 key eligib criteria: mcrpc with &gt;=2 untreated bone mets visible on bone scan &amp; psma-positive disease on psma pet (suvmax 20) co-prim obj: mtd of ra-223 + 
Uro Onc @GACancerCenter | Res PD & Ronald W. Lewis MD Chair of Uro Educ @mcg_urology | Digital Media Ed @EUplatinum | #mentalhealth research | @urotoday